Teva's Biosimilar Boom Just Beginnings: Is It Time to Buy?
Teva is turning the corner with a growing biosimilars roster and improving margins. This article examines whether tev...
Inadequate retirement planning can jeopardize your future. Learn to spot the warning signs to ensure your retirement is secure.
15,144 articlesTeva is turning the corner with a growing biosimilars roster and improving margins. This article examines whether tev...
Oracle stock dips despite a swelling backlog. This guide explains what backlog means, why the stock reacts, and how i...
SpaceX has captured headlines with a powerful first day. This article explains what could drive spacex stock headed h...
XRPL posted the strongest 90-day RWAs inflow among major blockchains, narrowly topping Ethereum and Solana. Analysts ...
June 18, 2026 marks kevin warsh’s first test as Fed chair, as hawkish voices push for a quicker path and markets seek...
The new FED chief presides over his first policy meeting, keeping rates steady while outlining a cautious, data-drive...
Public equity plays are moving to the front line of U.S. industrial policy. Intel’s strong run after government invol...
Tech-led gains paced a Nasdaq climb as investors reassessed hawkish Fed signals. The index rose, while traders weighe...
AppLovin is rebounding as AI ad-tech momentum returns, with analysts modeling upside to $600+ as AXON 2 expands and b...
In June 2026, Bitcoin traders face a new threat: boredom. CryptoQuant sees a protracted lull in demand as the real ri...
As the quarter winds down, Monday’s best Wall Street calls set the tone, spotlighting tech, energy and consumer names...
Regulators move away from wallet limits and toward a per product ceiling for sterling tokens, setting the stage for a...